On December 19, 2025, Quantum BioPharma Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who sold, or otherwise disposed, of the publicly traded stock of Quantum Biopharma Ltd., formerly known as FSD Pharma, Inc. (“Quantum” or the “Company”), during the Class Period.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.